Jimmy Lin
Jimmy is the lead computational biologist for the ground-breaking cancer genome sequencing efforts from the Vogelstein Lab at Johns Hopkins. Their sequencing of the first 100+ cancer exomes in 5 different tissue types has helped lay the foundation for a revolution in cancer genomics. After completing his MD/PhD at Johns Hopkins, along with colleagues at Harvard and Yale, Jimmy started Rare Genomics Institute: a non-profit biotech venture that microfunds and enables genome sequencing for children with orphan diseases.
Follow @cjimmylin

